Premium
A PHASE 2B RANDOMIZED STUDY OF SINGLE AGENT S ELINEXOR IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B ‐CELL LYMPHOMA ( DLBCL )
Author(s) -
Casasnovas R.,
Westin J.,
Thieblemont C.,
Zijlstra J.,
Hill B.,
De La Cruz Vicente F.,
Choquet S.,
Caimi P.,
Kaplan J.,
Canales M.,
Kuruvilla J.,
Follows G.,
Neste E.,
Meade J.,
Wrigley B.,
Devlin M.,
SaintMartin J.,
Nippgen C.,
Gardner H.,
Shacham S.,
Kauffman M.,
Maerevoet M.
Publication year - 2017
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.2438_53
Subject(s) - neutropenia , medicine , nausea , adverse effect , diffuse large b cell lymphoma , phases of clinical research , anemia , refractory (planetary science) , gastroenterology , vomiting , lymphoma , febrile neutropenia , oncology , toxicity , biology , astrobiology